Menu
Search
Subscribe

Tag: anetumab ravtansine

Bayer antibody-drug conjulate (ADC) misses in phase 2 mesothelioma trial

Business @leadernewspaper @leadernewspaper -
Bayer's antibody-drug conjulate (ADC) anetumab ravtansine has failed to show improvements in the survival rates of mesothelioma patients. Stock prices of Bayer's collaborators ImmunoGen...

Popular

Orihuela Launches Christmas Shop Window Decorating Contest

Business 0
The Department of Commerce has announced a Christmas Shop...

Orihuela Celebrates Children’s Day with Balloon rides and More

Entertainment 0
To commemorate Children’s Day, celebrated on November 20th, the...

Torrevieja Welcomes 23 New Civil Servants

Employment 0
Torrevieja welcomed 23 new civil servants to key departments...

Blocked Riverbed in Orihuela Costa Poses Major Flood Risk to hundreds of homes

Agriculture 0
A private individual has annexed 12,500 square meters of...

About us

Established in 2004, The Leader Newspaper is a popular read for English-language speakers in Spain who are interested in news, sport, Spanish property, business, classifieds, and local information.

Email: office@theleader.info
Tel./Whatsapp: +34 637 227 385

Company

Market Place

Spanish Property for Sale
Property for sale in Spain
Property for Sale in Orihuela-Costa
Property for Sale in Torrevieja
Long-Term Rentals Spain
Holiday Lettings Spain

© 2021 The Leader Digital. All Rights Reserved.